Skip to main content

Table 2 Patients’ demographic information and TRG

From: The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer

Study population

Gender

 Male

52

 Female

12

 Age, years

59.1 ± 7.9

Clinical T-stage

 T1

2

 T2

15

 T3

42

 T4

5

Clinical N-stage

 No

32

 N1

15

 N2

15

 N3

2

Type

 SCC

59

 AC

2

 ASC

3

Tumor Regression Grade

 1

4

 2

4

 3

7

 4

11

 5

38